ORNELLA ADDONIZIO: Open Payments
NPI 1154401149 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,930 in 99 payments from 9 companies in 2025. Trend: 2023 $1,004 · 2024 $1,508 · 2025 $1,930
Food & beverage: $1,825Education: $104
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 28 | $564 |
| Alkermes, Inc. | 25 | $495 |
| ABBVIE INC. | 24 | $408 |
| Teva Pharmaceuticals USA, Inc. | 7 | $217 |
| Vanda Pharmaceuticals Inc. | 10 | $138 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: CAPLYTA, ARISTADA, VRAYLAR, FANAPT, AUSTEDO XR, REXULTI, LYBALVI, TRINTELLIX.
Industry payments across CA — which companies pay providers there.
